Kelun Lifesciences (Pvt) Ltd, a BOI company and one of the largest pharmaceutical manufacturing facilities in Sri Lanka, in the Kandy Industrial Park, fulfils 40 percent of total demand for saline in the country.
This came to light during a visit to the Industrial Park by Investment Promotion State Minister Dilum Amunugama, Board of Investment (BOI) Director General Renuka M. Weerakone and Executive Director, Zones, M. K. D. Lawrance. Kelun Lifesciences, an Indian investment, which commenced operations in 2017 and employs over 225 people, has saved over Rs. 1.5 billion through the manufacture of saline locally since then.
During the visit, the State Minister chaired a meeting with the investors of the Industrial Park, to discuss and iron out the issues faced by them.
Amunugama said, “It is evident and undeniable that local production and export have been largely hit by global and local recessions resulting in low production and exports.
“In this context, the Government is keen on taking pertinent measures to ensure the smooth operation of the local industries in the face of the global and local economic setbacks,” he said. The Investment Promotion Ministry is in the process of making short-term and long-term strategies to address the issues confronted by the industries so that they could carry on operations without a hitch, he said. The Kandy Industrial Park comprising 114 acres of land, houses 24 factories with over 10,400 workers.